Glaucoma, a leading cause of blindness, demands innovative management strategies. Glaucoma: New therapies and surgical techniques explore minimally invasive glaucoma surgeries (MIGS), such as trabecular meshwork stents, which offer safer alternatives to traditional procedures. Novel pharmacological agents, including rho kinase inhibitors, enhance trabecular outflow, reducing intraocular pressure. Sustained-release drug delivery systems promise improved patient compliance. Diagnostic advancements, like optical coherence tomography angiography, enable earlier detection of optic nerve damage. These developments allow personalized treatment plans, balancing efficacy and safety. Surgeons are adopting laser-based techniques, such as selective laser trabeculoplasty, for precise pressure control. Continuous research and clinical trials are critical to refining these approaches, ensuring better outcomes for patients at risk of vision loss.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Diagnostic uncertainty with a patient presenting with raised intra-ocular pressure. A unique case of choroidal melanoma
Raheel Faiz, UHCW, United Kingdom
Title : Subthreshold micropulse laser for residual subretinal fluid after vitrectomy in myopic tractional maculopathy?A randomized controlled trial
Zhang Xifang, Beijing Tongren Hospital, China
Title : Hitting the trifecta-ocular syphilis
Lisa Sunny, Aravind Eye Hospital, India
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and vision Disorders, Poland